Suppr超能文献

双侧同步男性乳腺癌:一例报告。

Bilateral and synchronous male breast cancer: a case report.

作者信息

Zhou Shaoqiang, Wang Jiankui, Li Ming, Yang Yinju, Zhang Hushan, Chen Dedian

机构信息

Department of Breast Surgery, The Third Affiliated Hospital of Kunming Medical University Kunming 650032, Yunnan, P. R. China.

The Medical Department, 3D Medicines Inc. Shanghai 201114, P. R. China.

出版信息

Int J Clin Exp Pathol. 2023 Nov 15;16(11):352-356. eCollection 2023.

Abstract

Genetic mutational characterization of synchronous bilateral male breast cancer (BC) has been poorly reported due to its rarity. Herein, we present a 55-year-old male patient who was diagnosed with bilateral breast cancer (BBC) and harbored different gene mutations. The diagnosis of synchronous bilateral breast cancer (SBBC) was made using ultrasonography, magnetic resonance imaging (MRI), mammography and core-needle biopsy. Subsequently, bilateral modified radical mastectomies were performed, and histopathologic examination revealed invasive ductal carcinoma. To further investigate the genetic profile of the patient, the biopsy tissue from both breasts and a blood sample were subjected to targeted next generation sequencing (NGS). The genomic profile of the left breast (LB) sample revealed two copy number variations (CNVs), amplification of MCL1 and DAXX, while the right breast (RB) sample showed no obvious mutation. We are reporting this case along with its clinicopathologic findings and genetic investigations, since SBBS occurs extremely rarely, especially in men. The heterogeneity in gene mutations observed in this case may suggest a different pathogenesis and the need for different therapy strategies.

摘要

由于同步双侧男性乳腺癌(BC)极为罕见,其基因突特征的报道较少。在此,我们报告一名55岁男性患者,他被诊断为双侧乳腺癌(BBC)且携带不同基因突变。通过超声、磁共振成像(MRI)、乳腺X线摄影和粗针活检确诊为同步双侧乳腺癌(SBBC)。随后,进行了双侧改良根治性乳房切除术,组织病理学检查显示为浸润性导管癌。为进一步研究该患者的基因图谱,对双侧乳房的活检组织和一份血液样本进行了靶向二代测序(NGS)。左乳(LB)样本的基因组图谱显示有两个拷贝数变异(CNV),即MCL1和DAXX的扩增,而右乳(RB)样本未显示明显突变。我们报告该病例及其临床病理结果和基因研究情况,因为SBBS极为罕见,尤其是在男性中。该病例中观察到的基因突变异质性可能提示不同的发病机制以及对不同治疗策略的需求。

相似文献

1
Bilateral and synchronous male breast cancer: a case report.
Int J Clin Exp Pathol. 2023 Nov 15;16(11):352-356. eCollection 2023.
2
Synchronous bilateral male breast cancer: a case report.
J Breast Cancer. 2012 Jun;15(2):248-51. doi: 10.4048/jbc.2012.15.2.248. Epub 2012 Jun 28.
3
Synchronous bilateral breast cancer with different histology.
Radiol Case Rep. 2023 May 13;18(7):2491-2497. doi: 10.1016/j.radcr.2023.04.006. eCollection 2023 Jul.
4
Male breast cancer: presenting as synchronous, large, bilateral masses.
J Clin Diagn Res. 2014 Apr;8(4):FD07-8. doi: 10.7860/JCDR/2014/6769.4265. Epub 2014 Apr 15.
5
Synchronous bilateral solid papillary carcinomas of the breast.
Case Rep Surg. 2013;2013:812129. doi: 10.1155/2013/812129. Epub 2013 Jun 17.
8
Bilateral breast cancer in China: A 10-year single-center retrospective study (2006-2016).
Cancer Med. 2021 Sep;10(17):6089-6098. doi: 10.1002/cam4.4141. Epub 2021 Aug 4.

本文引用的文献

2
Understanding MCL1: from cellular function and regulation to pharmacological inhibition.
FEBS J. 2022 Oct;289(20):6209-6234. doi: 10.1111/febs.16136. Epub 2021 Aug 2.
3
Recruitment of KMT2C/MLL3 to DNA Damage Sites Mediates DNA Damage Responses and Regulates PARP Inhibitor Sensitivity in Cancer.
Cancer Res. 2021 Jun 15;81(12):3358-3373. doi: 10.1158/0008-5472.CAN-21-0688. Epub 2021 Apr 14.
4
Synchronous bilateral breast cancer in a male.
Ecancermedicalscience. 2013 Dec 4;7:377. doi: 10.3332/ecancer.2013.377. eCollection 2013.
6
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.
Nature. 2011 Mar 3;471(7336):110-4. doi: 10.1038/nature09779.
7
Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancer.
Clin Cancer Res. 2011 Mar 15;17(6):1591-602. doi: 10.1158/1078-0432.CCR-10-2307. Epub 2011 Jan 28.
8
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.
Science. 2011 Mar 4;331(6021):1199-203. doi: 10.1126/science.1200609. Epub 2011 Jan 20.
9
The ARF tumor suppressor: structure, functions and status in cancer.
Int J Cancer. 2010 Nov 15;127(10):2239-47. doi: 10.1002/ijc.25511.
10
A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4.
Proc Natl Acad Sci U S A. 2009 May 26;106(21):8513-8. doi: 10.1073/pnas.0902873106. Epub 2009 May 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验